IMPPP phase 1 study
Research type
Research Study
Full title
Improving Medicines use in People with Polypharmacy in Primary Care (IMPPP): phase 1 study
IRAS ID
250105
Contact name
Dan Morales
Contact email
Sponsor organisation
University of Dundee
Duration of Study in the UK
3 years, 11 months, 31 days
Research summary
People are taking increasing number of prescribed medicines, and we know that this is associated with increased harm as well as increased benefit. Regular medicines review is recommended to optimise prescribing, but it is unclear how best to organise it. There are a number of NHS initiatives in this area in Scotland but fewer in England. This study is intended to learn from existing NHS initiatives in Scotland, in order to help design a new way of organising medicines review for people taking many medicines in England. Over six months or so, we will interview approximately 24 professionals and 20 patients in Scotland to understand different elements of NHS Scotland improvement work (eg education, computerised tools to make review easier, GPs and pharmacists working together). We will also analyse existing NHS data to better understand whether the NHS Scotland work leads to better prescribing. We will then design an intervention to use in England and present it to approximately 20 professionals and 10 patients in England for discussion. This application only refers to this work, but the findings will be immediately used to finalise an intervention to be piloted and then evaluated in a randomised trial in England (which will have separate ethical review).
REC name
London - Harrow Research Ethics Committee
REC reference
18/LO/1288
Date of REC Opinion
28 Sep 2018
REC opinion
Further Information Favourable Opinion